Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients

Objective: Colorectal cancer is the fourth most common malignant tumor in the world, and survival times are seen to increase together with the increase in the options for targeted therapies, local ablative applications, and supportive care. The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) sco...

Full description

Saved in:
Bibliographic Details
Main Author: Zeynep Güç
Format: Article
Language:English
Published: Selcuk University Press 2022-10-01
Series:Genel Tıp Dergisi
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/2669084
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563617924743168
author Zeynep Güç
author_facet Zeynep Güç
author_sort Zeynep Güç
collection DOAJ
description Objective: Colorectal cancer is the fourth most common malignant tumor in the world, and survival times are seen to increase together with the increase in the options for targeted therapies, local ablative applications, and supportive care. The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) score is used as a prognostic factor in different types of cancers. The aim of this study was to analyze the prognostic value of the HALP score in patients diagnosed with de novo metastatic colorectal cancer. Methods: De novo mCRC patients who were followed-up in the period from January 2017 to December 2021, were retrospectively evaluated. The optimal cut-off point for the HALP score was calculated with the Receiver Operating Characteristic (ROC) curve analysis. Predictive factors for overall survival were assessed with univariate analysis. Survival times were assessed with the Kaplan-Meier analysis. Results: A total of 213 patients were included in the study. Univariate analysis showed that patients with low BMI, high ECOG score, and tumors located in the right colon, and RAS mutant patients, and those with a low HALP score were associated with worse survival rates. Namely, the overall survival time of patients with a HALP score >16.74 was found as 91 months, while the overall survival time of patients with a HALP score ≤16.74 was found as 16 months (p<0.001). Conclusion: Our study showed the HALP score to be a simple, cost-effective, and useful marker that can predict OS in mCRC patients.
format Article
id doaj-art-653bcc4cdbaf42acb5806c6f44e4985e
institution Kabale University
issn 2602-3741
language English
publishDate 2022-10-01
publisher Selcuk University Press
record_format Article
series Genel Tıp Dergisi
spelling doaj-art-653bcc4cdbaf42acb5806c6f44e4985e2025-01-02T23:43:04ZengSelcuk University PressGenel Tıp Dergisi2602-37412022-10-0132557758210.54005/geneltip.1179659154Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer PatientsZeynep Güç0IZMIR KATIP CELEBI UNIVERSITYObjective: Colorectal cancer is the fourth most common malignant tumor in the world, and survival times are seen to increase together with the increase in the options for targeted therapies, local ablative applications, and supportive care. The Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) score is used as a prognostic factor in different types of cancers. The aim of this study was to analyze the prognostic value of the HALP score in patients diagnosed with de novo metastatic colorectal cancer. Methods: De novo mCRC patients who were followed-up in the period from January 2017 to December 2021, were retrospectively evaluated. The optimal cut-off point for the HALP score was calculated with the Receiver Operating Characteristic (ROC) curve analysis. Predictive factors for overall survival were assessed with univariate analysis. Survival times were assessed with the Kaplan-Meier analysis. Results: A total of 213 patients were included in the study. Univariate analysis showed that patients with low BMI, high ECOG score, and tumors located in the right colon, and RAS mutant patients, and those with a low HALP score were associated with worse survival rates. Namely, the overall survival time of patients with a HALP score >16.74 was found as 91 months, while the overall survival time of patients with a HALP score ≤16.74 was found as 16 months (p<0.001). Conclusion: Our study showed the HALP score to be a simple, cost-effective, and useful marker that can predict OS in mCRC patients.https://dergipark.org.tr/tr/download/article-file/2669084hemoglobin-albumin-lymphocyte-platelet (halp) scoremetastaticcolorectal cancerprognostic
spellingShingle Zeynep Güç
Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
Genel Tıp Dergisi
hemoglobin-albumin-lymphocyte-platelet (halp) score
metastatic
colorectal cancer
prognostic
title Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
title_full Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
title_fullStr Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
title_full_unstemmed Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
title_short Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
title_sort halp score a simple and easily accessible index for predicting prognosis in colorectal cancer patients
topic hemoglobin-albumin-lymphocyte-platelet (halp) score
metastatic
colorectal cancer
prognostic
url https://dergipark.org.tr/tr/download/article-file/2669084
work_keys_str_mv AT zeynepguc halpscoreasimpleandeasilyaccessibleindexforpredictingprognosisincolorectalcancerpatients